Project Grant HT94252510611
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$723K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $723,948.00 to the University of Alabama at Birmingham (UAB) to study the role of adaptive immune activation in solvent-induced Parkinson's neurodegeneration. The project will be conducted over the period of Aug 1, 2023 to Jul 31, 2026. UAB is a public research university known for its innovative and interdisciplinary approach to education, and has...
This Project Grant award of $650,845, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research at the University of Alabama at Birmingham (UAB) focused on developing macrophage-centric prognostic biomarkers for checkpoint blockade immunotherapy in melanoma. The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical...
The University of Alabama at Birmingham was awarded a $220,326 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on April 1, 2025, with a completion date of March 31, 2027, supports the development of novel, selective PARP protein degraders for prostate cancer treatment, utilizing PSMA uptake enhancement. This research aims to transform healthcare for military service members, veterans, and the broader...
The University of Alabama at Birmingham (UAB) was awarded a $2,069,849 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The award will support UAB's research from May 1, 2023 to April 30, 2027 to understand cardiovascular disease in mental health and stress disorders. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research,...
This Project Grant award of $1,177,716.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports research at the University of Alabama at Birmingham (UAB) to investigate the "Metabolic Regulation of Metastatic Potential Through mRNA Translation." The award, which began on July 15, 2024 and will run through July 14, 2028, aims to advance scientific understanding of cancer metastasis through the study of metabolic processes and...
The University of Alabama at Birmingham (UAB) was awarded a $733,662 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, supports research to investigate the role of tumor glycans in immune suppression. This federally funded project aims to advance scientific understanding of how specific carbohydrate molecules on tumor cells can inhibit the body's immune response, with the goal of...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $227,167 to the University of Alabama at Birmingham (UAB) to conduct research on "Macrophage-Centric Prognostic Biomarkers for Checkpoint Blockade Immunotherapy in Melanoma." The award period runs from July 1, 2025 to June 30, 2028. UAB, a prominent public research university known for its biomedical research capabilities, will leverage its expertise to...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $1,485,001.00 to the University of Alabama at Birmingham (UAB) to conduct research on "Overcoming Perturbations that Orchestrate Immune Exhaustion and Dysfunction in Breast Cancer." The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions to address...
The University of Alabama at Birmingham (UAB) received a $1,599,981.00 Project Grant award from the Defense Health Agency on June 1, 2024 under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to activate immune reserves and prevent secondary bacterial lung infections after trauma and hemorrhage. This biomedical research project aims to improve health outcomes for military service members and the broader public. The project will be conducted over a...
This federal Project Grant award of $1,317,584.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Alabama at Birmingham (UAB) aimed at developing macrophage-centric prognostic biomarkers for checkpoint blockade immunotherapy in melanoma. The 3-year project, which commenced on July 1, 2025, leverages UAB's extensive biomedical research capabilities and expertise in areas such as cancer,...